We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OPDP Warns Michigan Drugmaker for Product Claims, Missing Warnings
OPDP Warns Michigan Drugmaker for Product Claims, Missing Warnings
The FDA’s Office of Prescription Drug Promotion sent an untitled letter to Rockwell Medical of Wixom, Michigan over its web page for Triferic (ferric pyrophosphate citrate), an iron-replacement for adults with hemodialysis-dependent chronic kidney disease.